nipradilol has been researched along with 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iizuka, Y; Kashiwagi, K; Tsukahara, S | 1 |
1 other study(ies) available for nipradilol and 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide
| Article | Year |
|---|---|
Neuroprotective effects of nipradilol on purified cultured retinal ganglion cells.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Animals, Newborn; Antihypertensive Agents; Cell Separation; Cell Survival; Cells, Cultured; Culture Media, Serum-Free; Cyclic N-Oxides; Dose-Response Relationship, Drug; Flow Cytometry; Imidazoles; Neuroprotective Agents; Nitric Oxide; Propanolamines; Quinazolines; Rats; Rats, Sprague-Dawley; Retinal Ganglion Cells; Timolol | 2002 |